首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Differential effect of a low-molecular-weight heparin (dalteparin) and unfractionated heparin on platelet interaction with the subendothelium under flow conditions.
【24h】

Differential effect of a low-molecular-weight heparin (dalteparin) and unfractionated heparin on platelet interaction with the subendothelium under flow conditions.

机译:低分子量肝素(达肝素)和普通肝素在血流条件下对血小板与内皮下膜相互作用的差异作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Effects of heparins on platelet function are controversial, but perfusion studies, that simulate physiological conditions, might help to explain their clinical behaviour. We used a perfusion system to test the effect unfractionated heparin and a low-molecular-weight heparin (dalteparin, Fragmin) on platelet adhesion promoted by a damaged vascular surface. Normal blood samples containing increasing concentrations of unfractionated heparin and dalteparin were perfused through annular chambers containing enzymatically denuded rabbit aorta segments (5 min at 800 sec-1). Segments were evaluated morphometrically measuring the total surface covered by platelets and by large aggregates (thrombi). Unfractionated heparin inhibited platelet interaction with subendothelium in a lesser extent than dalteparin in both covered surface and thrombi (p < 0.01). At heparin doses that caused maximal inhibition covered surface was 10.0% +/- 3.1% with dalteparin and 18.3% +/- 4.2% with unfractionated heparin, and thrombi were 5.6% +/- 3.2% and 12.3% +/- 3.0%, respectively. These results may collaborate to explain some differences observed in the clinical results obtained with unfractionated heparin and with dalteparin.
机译:肝素对血小板功能的影响是有争议的,但是模拟生理状况的灌注研究可能有助于解释其临床行为。我们使用灌注系统测试普通肝素和低分子量肝素(达肝素,Fragmin)对受损血管表面促进的血小板粘附的作用。通过包含酶促剥蚀的兔主动脉节段的环形腔室灌注含有浓度不断增加的普通肝素和达肝素的正常血液样本(800秒-1时5分钟)。通过形态计量学评估节段,测量血小板和大聚集体(血栓)覆盖的总表面。在覆盖的表面和血栓中,普通肝素对血小板与内皮下的相互作用的抑制作用均比达肝素稍弱(p <0.01)。在肝素引起最大抑制作用的剂量下,达肝素为10.0%+/- 3.1%,普通肝素为18.3%+/- 4.2%,血栓为5.6%+/- 3.2%和12.3%+/- 3.0%,分别。这些结果可以共同解释未分级肝素和达肝素在临床结果中观察到的一些差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号